HKEX(HK:00388) Xin Lang Cai Jing·2025-10-23 07:50Core Insights - Hong Kong Exchanges and Clearing Limited (HKEX) is committed to enhancing collaboration with various parties, optimizing listing arrangements, and expanding connectivity mechanisms to promote the development of capital markets in both Hong Kong and mainland China [1][2] Group 1: Market Performance - Since September of the previous year, China's investment opportunities have gained global investor attention, leading to strong performance in the Hong Kong market, with trading volumes in the securities and derivatives markets reaching six-month highs [1] - As of September 30, 2023, the total IPO financing amount for the year reached HKD 182.9 billion, more than doubling compared to the same period in 2024 [1] - The average daily trading volume in the Hong Kong securities market was HKD 256.4 billion, a year-on-year increase of 126% [1] - The derivatives market saw an average daily trading volume of 1.68 million contracts, an increase of 11% year-on-year [1] Group 2: Strategic Developments - HKEX plans to launch the Hang Seng Biotechnology Index futures to meet the growing risk management needs of investors in the biotechnology sector [2] - The company is collaborating closely with the Shanghai and Shenzhen stock exchanges to incorporate REITs into the Stock Connect, introduce block trading mechanisms, and include RMB counters in the Hong Kong Stock Connect [2] - HKEX aims to enhance the international competitiveness of the Hong Kong stock market and cater to the diverse investment needs of global investors, including those from mainland China [2] - As a leading offshore RMB center, HKEX will continue to build a competitive ecosystem for fixed income and currency products, providing various asset allocation and risk hedging tools to support the steady internationalization of the RMB [2]